"Beclomethasone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA.
| Descriptor ID |
D001507
|
| MeSH Number(s) |
D04.210.500.745.432.769.125 D04.210.500.883.154
|
| Concept/Terms |
Beconase- Beconase
- Becloforte
- Becodisk
- Becodisks
- Propaderm
- Becotide
- Sanasthmyl
Qvar- Qvar
- Ecobec
- Beclazone
- Beclazone Easy Breathe
- Ventolair
- Prolair
- Filair
- Filair Forte
- AeroBec Forte
- Aerobec
- Nasobec Aqueous
- Respocort
|
Below are MeSH descriptors whose meaning is more general than "Beclomethasone".
Below are MeSH descriptors whose meaning is more specific than "Beclomethasone".
This graph shows the total number of publications written about "Beclomethasone" by people in this website by year, and whether "Beclomethasone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2017 | 5 | 4 | 9 |
| 2018 | 6 | 0 | 6 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Beclomethasone" by people in Profiles.
-
Long-term olfactory dysfunction following coronavirus disease 2019 infection, routine neck dissection at salvage laryngectomy, parotid incidentalomas, and prescribing intranasal steroids in HIV infection. J Laryngol Otol. 2021 Sep; 135(9):753-754.
-
Clinical trials of inhaled beclomethasone and mometasone for COVID-19 should be conducted. J Med Virol. 2021 02; 93(2):637-638.
-
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation. Eur Respir J. 2019 05; 53(5).
-
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA. Int J Chron Obstruct Pulmon Dis. 2019; 14:531-546.
-
Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide as a combination therapy for chronic obstructive pulmonary disease. Expert Rev Respir Med. 2019 01; 13(1):5-11.
-
Small airway inflammation and extrafine inhaled corticosteroids plus long-acting beta2-agonists formulations in chronic obstructive pulmonary disease. Respir Med. 2018 10; 143:74-81.
-
Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease. Expert Opin Pharmacother. 2018 Aug; 19(11):1279-1287.
-
Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide. Int J Chron Obstruct Pulmon Dis. 2018; 13:2319-2333.
-
Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways. Respir Res. 2018 04 12; 19(1):65.
-
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Lancet. 2018 03 17; 391(10125):1076-1084.